Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
334.85
0.00 (0.00%)
Nov 1, 2024, 8:30 AM EST - Market closed
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$411.00
Upside
+22.74%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Maintains $400 → $450 | Strong Buy | Maintains | $400 → $450 | +34.39% | Oct 31, 2024 |
RBC Capital | RBC Capital | Buy Maintains $446 → $469 | Buy | Maintains | $446 → $469 | +40.06% | Oct 31, 2024 |
Citigroup | Citigroup | Hold → Strong Buy Upgrades $350 → $400 | Hold → Strong Buy | Upgrades | $350 → $400 | +19.46% | Oct 1, 2024 |
Wells Fargo | Wells Fargo | Hold Initiates $340 | Hold | Initiates | $340 | +1.54% | Aug 27, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $401 | Buy | Reiterates | $401 | +19.76% | Aug 16, 2024 |
RBC Capital | RBC Capital | Buy Maintains $402 → $401 | Buy | Maintains | $402 → $401 | +19.76% | Aug 2, 2024 |
Citigroup | Citigroup | Hold Maintains $300 → $350 | Hold | Maintains | $300 → $350 | +4.52% | Aug 2, 2024 |
UBS | UBS | Strong Buy Maintains $420 → $385 | Strong Buy | Maintains | $420 → $385 | +14.98% | May 8, 2024 |
Citigroup | Citigroup | Strong Buy → Hold Downgrades $400 → $365 | Strong Buy → Hold | Downgrades | $400 → $365 | +9.00% | Apr 3, 2024 |
UBS | UBS | Strong Buy Maintains $395 → $420 | Strong Buy | Maintains | $395 → $420 | +25.43% | Feb 16, 2024 |
RBC Capital | RBC Capital | Buy Maintains $484 → $480 | Buy | Maintains | $484 → $480 | +43.35% | Feb 16, 2024 |
UBS | UBS | Strong Buy Initiates $395 | Strong Buy | Initiates | $395 | +17.96% | Dec 7, 2023 |
Wells Fargo | Wells Fargo | Buy Maintains $550 → $525 | Buy | Maintains | $550 → $525 | +56.79% | Aug 7, 2023 |
RBC Capital | RBC Capital | Buy Maintains $522 → $524 | Buy | Maintains | $522 → $524 | +56.49% | Aug 4, 2023 |
Credit Suisse | Credit Suisse | Buy Maintains $580 → $550 | Buy | Maintains | $580 → $550 | +64.25% | Aug 4, 2023 |
Wells Fargo | Wells Fargo | Buy Initiates $550 | Buy | Initiates | $550 | +64.25% | Jun 16, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.